Y A Kucheryavyy

48PUBLICATIONS

157CO-AUTHORS

Behavioural epidemiologyEpidemiological methodsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (48)

Sort by Publication Date:

|Jun 26, 2026

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

|May 04, 2026

Efficacy and Safety of Tegoprazan in Helicobacter pylori Eradication: An Umbrella Review of Meta-Analyses.

|Jan 28, 2026

Rebamipide as an Adjunctive Therapy for Gastrointestinal Diseases: An Umbrella Review.

Igor V Maev, Alsu R Khurmatullina, Dmitrii N Andreev

|Oct 28, 2025

Tailored Therapy vs. Empirical Therapy for Helicobacter pylori Eradication: An Umbrella Review of Systematic Reviews and Meta-Analyses.

Dmitrii N Andreev, Alsu R Khurmatullina, Igor V Maev

|Aug 30, 2025

[Study on the efficacy of combination therapy with rifaximin and Saccharomyces boulardii CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors].

I V Maev, D N Andreev, R I Shaburov

|Aug 30, 2025

[Serological markers as predictors of the severity of gastric mucosal atrophy in autoimmune and Helicobacter рylori-associated gastritis].

M V Chebotareva, K A Nikolskaya, D N Andreev

Pageof 8

Frequent Collaborators

36 joint publications

Igor V Maev

16 joint publications

Dmitry S Bordin

15 joint publications

Yury A Kucheryavyy

11 joint publications

Philipp S Sokolov

10 joint publications

Aleksey K Fomenko

10 joint publications

Andrey V Zaborovskiy

9 joint publications

А R Khurmatullina

6 joint publications

Elena N Ilina

5 joint publications

M K Devkota